Evidence map›Paper›PMID 39554218›Full record

ArticleChina CDC weekly2024

Trends in the Mortality Rate of Major Kidney Diseases - China, 2014-2021.

Xinhui Yu, Jinlei Qi, Peng Yin, Limin Wang, Yunning Liu, Maigeng Zhou, Lijun Wang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in China CDC weekly, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xinhui YuNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Jinlei QiNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Peng YinNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Limin WangNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Yunning LiuNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Maigeng ZhouNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
Lijun WangNational Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Kidney disease represents a significant public health issue in China, yet there is a lack of comprehensive knowledge regarding national and regional trends in its mortality and causes. This study evaluated the mortality, causes, and regional distribution of major kidney diseases in China from 2014 to 2021. Methods: Data pertaining to kidney disease were obtained from the National Death Cause Surveillance System. Estimates were made for both the mortality rates and age-standardized mortality rates (ASMR) for kidney cancer, glomerular disease, tubulointerstitial nephritis, and kidney failure. Additionally, the average annual percent change (AAPC) was calculated to illustrate trends by sex, urban/rural distinctions, and regional differences from 2014 to 2021. Results: There was a significant reduction in the ASMR for all kidney diseases combined from 2014 to 2021. Analysis of age-specific mortality rates reveals a gradual increase beginning at age 35, with a sharp rise after age 60. However, the ASMR for glomerular disease and kidney failure in females, as well as for tubulointerstitial nephritis in males, displayed a notable decrease. Regionally, the ASMR for glomerular disease in the eastern region and kidney failure in the western region significantly decreased by AAPC of -4.6% and -2.3%, respectively. Conversely, the ASMR for kidney cancer in the central region rose significantly (AAPC=2.1%). Conclusion: From 2014 to 2021, the ASMR for major kidney diseases remained high among men, urban residents, and individuals in western China. Future prevention and control initiatives should prioritize these disparities to mitigate the impact of kidney diseases.

Indexed as

Kidney DiseaseMortalityVariation Tendency

Identifiers

PMID39554218
PMCPMC11561366

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.